Anygen Co., Ltd. (196300) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Anygen Co., Ltd. (196300:KRX), powered by AI.

Current Price
₩5,080
P/E Ratio
-74.1
Market Cap
47.6B
Sector
Basic Materials
What is the Anygen Co., Ltd. stock price forecast?

Anygen Co., Ltd. is currently trading at ₩5,080. View real-time AI analysis on Alpha Lenz.

What is Anygen Co., Ltd. insider trading activity?

View the latest insider trading data for Anygen Co., Ltd. on Alpha Lenz.

What is Anygen Co., Ltd.'s P/E ratio?

Anygen Co., Ltd.'s P/E ratio is -74.1.

Anygen Co., Ltd.

KRX · 196300
₩5,080+110(+2.21%)Market closedKRX regular session 09:00–15:30 KST
Ask about Anygen Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Anygen Co., Ltd. trades at a P/E of -74.1 (undervalued) with modest ROE of -4.1%.

Ask for details

Company Overview

Anygen Co., Ltd. is a prominent biotechnology company specializing in the research and development of peptide-based therapeutics and raw materials. This company focuses on the creation of cutting-edge peptide technologies that serve various applications in pharmaceuticals, cosmetics, and healthcare industries. By harnessing advanced biochemical methods, Anygen Co., Ltd. contributes significantly to the development of innovative drugs and cosmetic products, improving health and wellness worldwide. Operating within the competitive biotechnology sector, Anygen Co., Ltd. plays a pivotal role in advancing medical treatments and cosmetic formulations. Its expansive research operations are aimed at increasing the efficacy and safety of peptide-based solutions, which offer promising alternatives to conventional synthetic pharmaceuticals. As a key player in the biotechnology market, the company's innovations drive progress across multiple industries, showcasing its importance in both therapeutic and cosmetic advancements. Through collaborative efforts with other scientific entities and constant innovation, Anygen Co., Ltd. maintains its influence in the growing field of biotechnology, contributing substantially to the global pursuit of enhanced human health and quality of life.

CEO김재일, 심경재 (각자 대표)
SectorBasic Materials
IndustryChemicals
0

Company Statistics

FY 2025

Profile

₩47,632,310,120Market Cap
₩4,961,730,620Revenue
9.38MShares Out
0Employees

Margins

-35.15%Gross
-87.78%EBITDA
-147.53%Operating
-12.39%Pre-Tax
-12.95%Net

Valuation

-74.14P/E
1.85P/B
9.60EV/Sales
-14.47EV/EBITDA
-4.33P/FCF

Growth (CAGR)

-16.95%Rev 3Yr
-10.24%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.83%ROA
-4.13%ROE
6.50%ROIC

Financial Health

₩1,510,210,730Cash & Cash Equivalents
₩26,563,585,670Net Debt
109.09%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Anygen Co., Ltd. (ticker: 196300) is a company listed on KRX in the Basic Materials sector (Chemicals). Market cap is $47.6B.

The current price is ₩5,080 with a P/E ratio of -74.14x and P/B of 1.85x.

ROE is -4.13% and operating margin is -147.53%. Annual revenue is $5.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Anygen Co., Ltd. (196300) Stock Forecast 2026 ₩5,080 — Price, Financials & Analyst Targets | Alpha Lenz